Efficacy and safety of immune-modulating therapy for primary sclerosing cholangitis: A systematic review and meta-analysis.

Liu, Xin; Wang, Haolu; Liu, Xinyao; Bridle, Kim; Crawford, Darrell; Liang, Xiaowen

Liu, Xin; Wang, Haolu; Liu, Xinyao; Bridle, Kim; Crawford, Darrell; Liang, Xiaowen.

Afiliação

Liu X; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Wang H; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia; The Prince Charles Hospital, Chermside, QLD, Australia.
Liu X; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia.
Bridle K; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia; Gallipoli Medical Research Institute, Greenslopes Private Hospital, Brisbane, QLD, Australia.
Crawford D; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia; Gallipoli Medical Research Institute, Greenslopes Private Hospital, Brisbane, QLD, Australia.
Liang X; The University of Queensland Diamantina Institute, The University of Queensland, Woolloongabba, QLD 4102, Australia; Faculty of Medicine, The University of Queensland, Brisbane, QLD, Australia; Gallipoli Medical Research Institute, Greenslopes Private Hospital, Brisbane, QLD, Australia. Electronic a

Pharmacol Ther ; 237: 108163, 2022 09.

Article em En | MEDLINE | ID: mdl-35271884

Assuntos

Colangite Esclerosante; Colestase; Imunoterapia; Adulto; Fosfatase Alcalina/uso terapêutico; Bilirrubina/uso terapêutico; Biomarcadores; Colangite Esclerosante/complicações; Colangite Esclerosante/tratamento farmacológico; Colestase/tratamento farmacológico; Humanos; Imunomodulação; Estudos Observacionais como Assunto; Ensaios Clínicos Controlados Aleatórios como Assunto

Palavras-chave

Immune-modulating therapy; Meta-analysis; Primary sclerosing cholangitis

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colangite Esclerosante / Colestase / Imunoterapia Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colangite Esclerosante / Colestase / Imunoterapia Idioma: En Ano de publicação: 2022 Tipo de documento: Article